ASVAC 2017
Meet The Speakers
Bruce
Mr Bruce Langoulant

Read More


Mr Bruce Langoulant is the parent and co – carer of an adult daughter with multiple disabilities caused by pneumococcal meningitis. He is Chairperson of the Disability Services Commission of Western Australia , Chairperson of Meningitis Centre Australia , Vice President Asia Pacific Region of the International Confederation of Meningitis Organisations Ltd and an advocate for vaccine access to protect all from meningitis.

Read Less

Daniel-Payne
Daniel Payne, USA
US Centers for Disease Control and Prevention

Read More

Dr. Daniel C. Payne is an epidemiologist and Senior Scientific Advisor in the Division of Viral Diseasesat the US Centers for Disease Control and Prevention. 

He is the Principal Investigator for a primary, multi-site active surveillance network for both acute gastroenteritis and acute respiratory illnesses in children in the US.

Read Less

De-La-Vega
Shelley Ann F. De la Vega, MD, MSc, FPCGM Philippines
Institute on Aging – National Institutes of Health

Read More


Dr. Shelley de la Vega is a Professor of the Department of Medicine, University of the Philippines College of Medicine and founding Director of the Institute on Aging, University of the Philippines Manila – National Institutes of Health. She is the Vice President of the Philippine Foundation for Vaccination. She assists the Department of Health, DSWD, National Academy of Science and Technology and various NGOs as technical consultant.
Dr. De la Vega completed her BS Psychology, cum laude at the University of the Philippines Diliman and Doctor of Medicine, University of the Philippines College of Medicine, Manila. She trained in Internal Medicine at the State University of New York (Downstate), after which she served as Chief Resident. She completed a 2-year Fellowship in Geriatric Medicine at the Division on Aging, Harvard Medical School, Boston, USA. She received her board certificate in Internal Medicine and Geriatric Medicine from the American Board of Internal Medicine. She completed her Master of Science in Clinical Epidemiology at the University of the Philippines Manila.
As a teacher, she has been responsible for incorporating geriatrics in the medical curriculum of the UP College of Medicine. She teaches medical students, Internal Medicine residents and fellows. She has given talks on themes on aging and non-communicable diseases to almost all major physician, nursing and allied medical societies in the Philippines. She was the organizer of the first International Conference on Longevity and Public Health in Manila; the Asia-Pacific Geriatric Conference in Cebu; and the National Conferences on Aging in Tacloban Leyte and Panay. She also enjoys being a lay educator to various citizens’ organizations, and is a frequent guest in television and radio talk shows.
She assists the Department of Health, DSWD, National Academy of Science and Technology and various NGOs as technical consultant. She was the Chairperson of the Committee on Aging and Degenerative Diseases (COMADD), and the former Director of the Institute of Health Policy and Development Studies National Institutes of Health. She is also a member of the National Advisory Council on Active Aging (NAST). She is a founding director of the Alzheimer’s disease Association of the Philippines and is the Vice President of the Philippine Foundation for Vaccination. She has published local and international journal articles, book chapters, monographs, as well as policy documents on Geriatric healthcare services, vaccination, Alzheimer’s Disease management, healthcare financing and education.
Dr. Shelley is the first president of Philippine College of Geriatric Medicine, which was formed in 2011 after the merging of 2 existing Geriatric Medicine Societies of the Philippine Medical Association and Philippine College of Physicians. She is the founding Director for The Center of Healthy Aging, and the former Chief of the Section of Geriatrics at The Medical City Ortigas. She pioneered the establishment of the first Geriatric Multidisciplinary Outpatient Clinic in the Philippines at the Philippine General Hospital.

Read Less

Christopher
Christopher Head
MA FRSA MInstF

Read More

Chris Head is President of the international Confederation of Meningitis Organisations (CoMO), and a member of the Steering Committee of the Global Meningococcal Initiative. From 2007–2015 Chris was a trustee of Action Meningitis Malawi, and CEO of the Meningitis Research Foundation, which played a leading role in developing and campaigning for a vaccine against meningococcal meningitis type B, which was approved for inclusion in the UK’s infant vaccination schedule in September 2015. During this period he was also a member of the steering committee of the Meningitis Free World Initiative and an adviser to the Excellence in Paediatrics institute.

Chris has nearly 25 years’ experience in leadership of health organizations in the voluntary sector, including CEO roles at CLIC UK and Penny BrohnCancer Care.A long-standing member of the Institute of Fundraising, Chris was also a board member and Treasurer of the Association of Chief Executives of Voluntary Organisations, Chair of the Cancer Care Charities Partnership, and an advisory panel member for United Bristol NHS Healthcare Trust.                                                                                   

Confederation of Meningitis Organisations
The Confederation of Meningitis Organisations Inc. (CoMO) is an international member organization working to reduce the incidence and impact of meningitis worldwide. CoMO brings together patient groups, health professionals and organizations, meningitis survivors and families from more than 25 countries to help prevent meningitis through raising public awareness of meningitis through education, and advocating for vaccines to be available to families worldwide. CoMO also connects and resources a strong global network of members who make sure their communities have access to meningitis information and support.
http://www.comomeningitis.org/

Read Less

William
William Hausdorff, Belgium

Read More


Bill has worked to expedite the development and introduction of new and improved vaccines for over 25 years, first with the US Centers for Disease Control and Prevention and later at Wyeth and GSK Vaccines. In addition to facilitating the development of the current pneumococcal conjugate vaccines, he is the author of extensive publications on the epidemiology and prevention of S. pneumoniae disease.

William (Bill) Hausdorff has worked on the development, testing, registration, implementation and evaluation of a variety of pediatric vaccines for over 25 years.  He currently is an independent consultant, based in Brussels, Belgium.
He most recently worked with GlaxoSmithKline Vaccines, serving as Vice President, Scientific Affairs & Public Health, as Vaccine Development Leader, Pneumococcal Vaccines and as Director, Epidemiology & Scientific Strategy.
Previously employed by Wyeth Vaccines in the Scientific Affairs & Research Strategy group, he co-holds patents on the design of the 13-valent pneumo-coccal conjugate vaccine, receiving no royalties as is industry practice.
He has alsoserved as a Technical Advisor with the US Centers for Disease Control & Prevention, based at the US Agency for International Development in Washington DC and Cairo, Egypt.  There he worked to expedite introduction of new vaccines into developing country immunization programs.
He received a PhD in Biology from Johns Hopkins Univ./U.S. National Institutes of Health, with a post-doctoral fellowship in molecular pharmacology at Duke Univ.  He is the author of numerous scientific articles and book chapters, including extensive publications on the epidemiology and prevention of S. pneumoniaedisease.

Read Less

John
Prof. John S. Tam, Ph.D.
Chairman and Director
Asia Pacific Alliance for the Control of Influenza (APACI).

Read More


Visiting Professor,
Department of Applied Biology and Chemical Technology
The Hong Kong Polytechnic University.

Prior to joining the Hong Kong Polytechnic University, Prof. Tam had worked as Technical Officer of the Initiative for Vaccine Research at the World Health Organization (WHO), Geneva, and was responsible for the global research and development of seasonal and pandemic influenza vaccines as well as the focal point for influenza policy development under SAGE. He also served as Scientist at the Global Influenza Programme of WHO, Geneva and was responsible for the development and implementation of the WHO Public Health Research Agenda for Influenza. John also worked in a leading role in the pharmaceutical industry on vaccine research and development. Prior to these, he was Professor in the Department of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong for 18 years. Dr. Tam received his B.Sc. and M.Sc. degrees from the University of Toronto majoring in virology, microbiology and biochemistry, and his Ph.D. degree from the University of Hong Kong on virology. John has been active in the field of medical virology and his interest included influenza and other viral respiratory tract infections, viral diarrhoeal diseases, viral hepatitis and virus-associated cancers. He had published over 180 peer-reviewed articles relating to his fields of interest.

Read Less

Carl
Carl Kirkwood, Australia
Bill and Melinda Gates Foundation, USA.

Read More


Carl Kirkwood, PhD, is a Senior Program Officer in the Enteric and Diarrheal Diseases program, in the Global Health Division of the Bill and Melinda Gates Foundation, and leads the rotavirus initiative. Prior to joining the Foundation, Dr Kirkwood was group leader of the Enteric Virus Group, Murdoch Childrens Research Institute, which is co-located at The Royal Children’s Hospital, Australia. His research focused on infectious diseases of the gastrointestinal tract, specifically diarrheal disease caused by rotavirus and norovirus.

Read Less

Kim
Kim Mulholland, Australia
Kim Mulholland MBBS, FRACP, MD, Professorial Fellow,
Group Leader, Murdoch Childrens Research Institute

Read More


Kim Mulholland is an Australian paediatrician, trained at Melbourne University and the Royal Children’s Hospital, Melbourne. With post-graduate training in immunology, respiratory medicine and tropical medicine he joined the Medical Research Council Laboratories in 1989, where he developed a program of research covering all aspects of the problem of childhood pneumonia. This included studies of the aetiology, clinical signs, and treatment of pneumonia cases, with particular reference to very young infants and malnourished children. These studies guided WHO policy in the field and contributed to the development of the strategy of Integrated Management of Childhood Illness (IMCI), as well as guiding oxygen and antibiotic management for hospitalized children. His Hib vaccine trials were the first to demonstrate the capacity of conjugate vaccines to prevent bacterial pneumonia, and paved the way for Hib vaccine introduction in Africa. After six years in the Gambia he joined WHO where he oversaw the development of standardized methods for the evaluation of pneumonia vaccines in developing countries. Since leaving WHO in 2000 he has continued to work in the pneumonia field with particular emphasis on vaccines. He was one of the founders of the Global Action Plan for Pneumonia, and one of the leaders of the successful Hib Initiative project that saw the introduction of Hib vaccines into the poorest countries of the world. During the same period he established leading pneumococcal microbiology and immunology laboratories at the Murdoch Children’s Research Institute (MCRI), Melbourne, along with major field research programs in Vietnam, Fiji and Mongolia, and growing programs in Indonesia and Laos. He currently holds professorial appointments at the MCRI in Melbourne and the London School of Hygiene and Tropical Medicine in UK.

Read Less

VIDOR
VIDOR Emmanuel, France
Sanofi Pasteur

Read More


As a co-author of the “Poliovirus Vaccine – Inactivated” chapter of the “Vaccines” book since several editions, has been able to follow the evolution of the topic since more than 20 years, and is able to provide an industrial perspective from one of the main suppliers of IPV-containing vaccines.

Biography:
Working in the vaccine industry since 30 years and having held several positions within Sanofi Pasteur (and its ancestral companies) in R&D as Project Leader for several vaccines under development and as responsible of the Clinical Development Programs of several vaccines under development. Since 2010, works as an expert within Medical Affairs.
Graduated in Medicine (1983, Lyon, France), in Tropical Medicine (1983, Lyon, France), in Biostatistics (1984, Villejuif, France) and obtained a Master in Biological and Medical Sciences (1985, Lyon, France). Followed the Applied Epidemiology course in 1986 (IES CDC program, Veyrier du Lac, France).

Read Less

Mathuram
Mathuram Santosham, USA
Johns Hopkins Bloomberg School of Public Health, Department of International Health

Read More

Dr. Mathuram Santosham was born in Vellore, India and obtained his MBBS degree from the Jawaharlal Institute of Post Graduate Medical Education and Research in Pondicherry, India in 1970. He subsequently moved to the US and obtained Board Certification in Pediatrics and an MPH degree from the Johns Hopkins University. He also completed a Fellowship in Pediatric Infectious Diseases at Johns Hopkins Hospital.

Dr. Santosham was  the Founder and Director of the Johns Hopkins Center for American Indian Health f(CAIH) rom April 1991 to April 2016.  He is currently the Director Emeritus of CAIH. He holds Professorships in the Department of International Health and the Department of Pediatrics at Johns Hopkins University. He directed the Division of Health Systems for the Johns Hopkins Bloomberg School of Public Health from 2000-2009.

Dr. Santosham is internationally known for his work on oral rehydration therapy, childhood vaccines and dissemination of pediatric prophylactics to vulnerable populations worldwide. Working in partnership with Native American communities, he conducted landmark vaccine efficacy trials, including rotavirus vaccine, H. influenzae type b (Hib) conjugate vaccine, and pneumococcal conjugate vaccine. Native American children used to die from these diseases at rates 10 to 50 times the US average. Through his advocacy, these vaccines now save 3 to 5 million lives a year in the US and across the globe. In addition, Dr. Santosham worked with the White Mountain Apache Tribe to pioneer the use of oral rehydration solution (ORS), now known as “Pedialyte” in the US. Based on this evidence, ORS has become the standard of care for treating diarrheal dehydration, and is credited with saving 60 million lives since 1980. Dr. Santosham has become a global leader in the national and international dissemination of these public health strategies worldwide.

Dr. Santosham serves on numerous national and international committees to promote childhood health throughout the world. He consults for numerous international agencies including WHO, USAID, UNICEF and the Gates Foundation on aspects of child survival in over 30 countries. He is

the author of over 270 peer-reviewed journals and serves as a reviewer for several international medical journals. He is the recipient of numerous awards including the Thrasher Research Fund Award for Excellence in Research (1988), Maurice Hilleman Lecturer at CDC (2008), and the Bob Austrian Orator, for International Symposium on Pneumococcas and Pneumococcal Disease (2006). He was also awarded the Indian Health Service Directors Award for Career Service in 2011, recognizing his personal dedication, commitment and contribution to the overall Indian Health Service Research Program and the global impact of his work. He  received the Albert Sabin Gold Medal Award (http://www.sabin.org/updates/events/2014-albert-b-sabin-gold-medal-award) on April 29th 2014.  The Albert B. Sabin Gold Medal has been awarded annually since 1994 to a distinguished member of the research community who has made extraordinary contributions in the field of Vaccine sciences  or a complementary field.  On Oct 7th 2014, he  received the 2014 Fries Prize for Improving Health, “For his seminal research, vaccine development, policy, and advocacy toward the global prevention of Haemophilus influenza type b (Hib) disease saving each year more than 370,000 children’s lives (www.cdcfoundation.org/pr/2014/mathuram-santosham-receives-2014-fries-prize-improving-health). He is currently the chair of the ROTA council (http://rotacouncil.org) which is an organization that is dedicated to advocating for the use  of rotavirus vaccines around the world particularly in Asia and Africa.

Read Less

Enrique
Enrique A. Tayag, MD, PHSAE, FPSMID, CESO III
Philippines

Department of Health

Read More


Dr. Enrique A. Tayag is now 58 years old and is the current Official Spokesperson and Assistant Secretary in the Department of Health (DOH) and the concurrent Director IV at the Bureau of Local Health Systems Development also in the DOH. For more than 25 years, since graduating from the University of the East Ramon Magsaysay Medical Center (UERMMCI), Dr. Tayag has focused his career in public health, particularly Epidemiology, Health Systems and Universal Health Care.

Having earned his Medical degree from UERMMMCI in 1984, the Manila- born physician went to San Lazaro Hospital in Manila in 1988-1990 for Residency Training in Infectious Disease. He completed his training in Epidemiology in 1990-1992 through the Field Epidemiology Training Program (FETP) of the Department of Health. The FETP traced its roots from the Epidemic Intelligence Service of the US Centers for Disease Control and Prevention (CDC). In 1994, Dr. Tayag completed a two-month short course in Management for International Public Health at Emory University in Atlanta. The FMTP has strengthened the capacity of LGUs for evidence-based Public Health Decision Making and Continuous Quality Improvement.

He moved to Department of Health in 1998 and quickly earned laurels as he occupied various leadership positions in the bureaucracy. He became the first Director of the National Center for Infectious and Degenerative Diseases in 2000.

From 2001-2005, He served as the Assistant Regional Director of the DOH Center for Health Development-Central Luzon in San Fernando, Pampanga. Dr. Tayag established the Collaborating Center for Disease Prevention and Control of North Luzon.

He became the Director IV of the National Epidemiology Center (NEC) from 2005-2015. The NEC was designated the National Focal Point of the International Health Regulations since 2007. He led the country’s efforts to detect and contain the pandemic H1N1 in 2005 as well as numerous local outbreaks of dengue, malaria and HIV.

He was the President of the Philippine Society for Microbiology and Infectious Diseases (1998) and also the President of the Philippine Foundation for Vaccination Inc. from 2006-2011. He now seats as Board Member at the National Board of National Union of Career Executive Service Officers, a renowned organization of government technocrats.

His interviews in all media on public health issues have prepared him well in becoming the Official Spokesperson of the DOH since 2005. Just 14 years after graduating from UERM, he also earned a national honor: the Secretary of Health Award for Outstanding Epidemiologist given to him in 1998. He also earned more honors as Most Outstanding Alumnus (PUBLIC SERVICE) 50th Year Anniversary UERMMMC, 2007 and Most Outstanding Alumnus (COMMUNITY LEADERSHIP), UERMMMC 2009 Alumni Homecoming. In 2012, he received the Award as Most Outstanding Alumnus in Medicine during the Centennial Celebration of St. Agnes Academy in Legaspi, where he finished his primary education. For the second time, he was given the Secretary of Health Award for Outstanding Epidemiologist also in 2012.

Most recently, he attracted public awe and amazement as he continues to lead the government’s efforts to combat non-communicable diseases by inspiring them to embrace the healthy lifestyle through his routine dance exercises that has become viral in social media.

Read Less

iam-picture
Professor Iqbal Ahmad Memon

Read More

Professor Iqbal Ahmad Memon
Past President, Pakistan Pediatric Association 2012-2014
Member Standing committee, International Pediatric Association 2013-2016
Professor of Pediatrics, Gastroenterology, Hepatology & Nutrition
HOD Pediatrics, Sir syed College of Medical Sciences for Girls 
Faculty Agha Khan University of health sciences, Karachi, Pakistan
Member NITAG Polio, Pakistan
Patron, Child Survival Program, Govt. of Sindh, Pakistan
Chairman, Board of Trustees, Save Our Children, Karachi Pakistan
prof.iqbalmemon@gmail.com 
iqbalmemon.prof@gmail.com

I was born in Karachi in 1950, and started my medical education in 1967 at DOW Medical College Pakistan. Stayed in USA for 10 years for training in Pediatric Gastroenterology, Hepatology and Nutrition. Currently i am Professor of Pediatrics and Head of Department at Sir Syed Medical College in Karachi Pakistan. Also, serving as honorary Faculty at Aga Khan University in Karachi since October 1990. I am a standing member of International Pediatric Association 2013-2016, also a council member of Asian Pan Pacific Societies of Pediatric Gastroenterology, Hepatology & Nutrition (APPSPGHAN).

I am also a member of National Technical Advisory Groups [NITAG] for  Polio Pakistan.[WHO EMRO]

Following are the additional Positions that i hold:

  • Founding Member, Pakistan Pediatric Association G.I./ Liver and  Nutrition  group
  • Member, National Research Council, Ministry of  Health,  Pakistan
  • Chairman Expert Review committee Sindh, Polio Eradication Program. (since 1998)
  • Chairman National committee for Pre service IMNCI
  • Member Provincial Child Survival Steering Committee, Sindh, Pakistan
  • Provincial clinical coordinator / Technical Advisor IMNCI, Sindh, Pakistan
  • Member PPA I.D and Pulmonary group
  • Chairman Expert Review committee Sindh, Polio Eradication Program Pakistan. (since 1998)
  • Member Asian Strategic Alliance for Pneumococcal infection (ASAP)
  • Council member commonwealth Association of Pediatric Gastroenterology & Nutrition (CAPGHAN)
  • Advisory council Member Asian Pacific Pediatric Associations (APPA)
  • Standing Committee Member International Pediatric Association [2013-2016]
  • Chairman, Board of Trustees, Save our Children [ a tax exempted trust 1998 to-date] in Karachi Pakistan
  • Patron, Child Survival  Program, Government of Sindh, Pakistan

Read Less

Naveenkumar
Dr. Naveenkumar Hariram Thacker, India

Read More

Dr. Naveen Thacker, Director of Deep Children Hospital & Research Centre is also the President of Asia Pacific Pediatric Association (APPA).

 

 

Dr. Naveen Thacker
MD (Ped); FIAP

Dr. Naveen Thacker, a well-known Child Specialist of Gandhidham is the President of Asia Pacific Pediatric Association (APPA).He has received the Outstanding Asian Pediatrician Award2012, at APPA Congress in Sarawak, Malaysia.
He is also a recipient of Rotary International Regional Award for Polio-free World 2010, Rotary Ratna Award District 3050, 2010 and best Rotarian Award for outstanding services in Polio-plus program.
He is CSO representative to GAVI Alliance Board, and also Coordinator of Development of International Pediatric Association(IPA).
He was the National President of Indian Academy of Pediatrics in 2007 (www.iapindia.org)
He is the Director of Deep Children Hospital & Research Centre.
His work on Polio eradication is recognized internationally.  Presently he is the member of Indian Expert Advisory Group on Pneumococcal Vaccines and Measles & Rubella
He has also served as member of many committees of Government of India and ICMR like Immunization Action Group, ICMR Subcommittee on Polio Vaccine, ICMR Expert committee on Vaccines, Indian expert Group on Polio.

 

Read Less

Ping-Ing
Ping-Ing Lee, Taiwan
Professor

Read More

Dr. Ping-Ing Lee is a pediatric infectious disease specialist working at the Department of Pediatrics, National Taiwan University Children’s Hospital. He serves as the chair of the Advisory Committee on Immunization Practices in Taiwan and is also former president of Asian Society for Pediatric Infectious Diseases.

 

Dr. Ping-Ing Lee graduated from the medical faculty of the National Taiwan University, and obtained his Ph.D. from Institute of Clinical Medicine, National Taiwan University. He is currently serving as associate professor of the Department of Pediatrics at the College of Medicine, National Taiwan University, and is attending physician at the Department of Pediatrics, National Taiwan University Children’s Hospital. Dr. Lee serves as the chair of the Advisory Committee on Immunization Practices, Center for Disease Control, Department of Health, Taiwan. He is the leader of pediatrics in Taiwan. He is currently acting secretary-general of Taiwan Pediatrics Association and the president of Taiwan Immunization Vision and Strategy. He is also former president of Asian Society for Pediatric Infectious Diseases. Dr. Lee is engaged in pediatrics, infectious diseases, vaccination, pneumonia, hepatitis and gastroenteritis. He had won the Outstanding Asian Pediatrician Award (OAPA) 2012 from the Asia Pacific Pediatric Association. He has published more than one hundred peer-reviewed academic papers in English, and more than two hundreds health-related articles for the public in Chinese.

Read Less

Leong
Dr Leong Hoe Nam

Read More


Consultant Infectious Diseases Physician
38 Irrawaddy Road
#07-55 Mt Elizabeth Novena Specialist Centre
Singapore 329563

Dr Leong Hoe Nam is an Infectious Diseases Physician. He graduated from NUS in 1996, and obtained his MRCP and M Med in 2001. Thereafter, he began his advanced specialist training in infectious diseases. Dr Leong further pursued his interest in virology at the Royal Free and University College Medical School, London under a fellowship awarded by the National Medical Research Council. In 2008 he was awarded a second research fellowship to train at the University of Columbia, New York, on emerging pathogens.
Dr Leong was previously a consultant in the Department of Infectious Disease in SGH. Having left Singapore General Hospital, he continued his practice in Infectious Diseases at the private Raffles Hospital before setting up his own clinic at Mount Elizabeth Novena Hospital.

Research Interest

  1. General Virology. Beta-herpesviruses, Emerging and re-emerging pathogens.
  2. Molecular diagnostics

Read Less

Bruce
Dr. Ananda S. Bandyopadhyay, USA
Senior Program Officer – Polio
Bill & Melinda Gates Foundation

Read More


Ananda considers himself a foot-soldier in the battle to eradicate diseases.

Ananda grew up in Kolkata, India and completed his medical graduation from Calcutta National Medical College & Hospital (2005) and was a gold medalist from the University of Calcutta. He received his Master of Public Health (MPH) degree in Global Health from Harvard School of Public Health (2010).

In between (2006 – 2009), he worked for the polio eradication initiative in five states in India as a Surveillance Medical Officer with WHO and contributed to the successful and historic polio eradication effort and measles surveillance initiatives in India. He worked as an infectious disease epidemiologist at Rhode Island State Department of Health, US, for two years, before joining the Bill and Melinda Gates Foundation in June, 2012. As a Senior Program Officer at the Gates Foundation, he supports global polio vaccine research and product development initiatives across multiple countries and geographies, including South Asia, Latin America, Africa and Europe. His research is focused on generating data regarding the best use of polio vaccines to make the vaccines affordable and accessible to vulnerable and underserved populations.

Ananda is a guest lecturer for advanced degree programs in public health and infectious diseases in several globally renowned teaching venues including the Harvard University. Ananda’s work in promoting health and preventing diseases in remote corners of the world has been cited and covered by several leading scientific journals and media portals, and his photo-documentation of real-world vaccination initiatives have won him several awards and accolades.

Read Less

James
Dr. James Molton

Read More


Dr. Molton completed his undergraduate medical training at University College London. He worked for 2 years in the UK then moved to Australia to pursue his Basic Medical Training at Fremantle Hospital in Western Australia. He went on to complete Advanced Specialist Training in Infectious Diseases, working at the Alfred Hospital in Melbourne and then National University Hospital in Singapore.
He currently works as a Consultant in Infectious Diseases and Internal Medicine at NUH where his roles include Clinical Service Director for Infectious Diseases and head of the NUH Travel Clinic. During his time in Singapore he has pursued his interest in tropical and travel medicine, attaining a Certificate in Travel Health and completing the Gorgas Diploma in Tropical Medicine and Hygiene in Peru. He has performed volunteer clinics in Cambodia with NUS Medical School, and in the Philippines with the Singapore Red Cross following Typhoon Haiyan.
Dr. Molton is project lead for a number of clinical research studies under the Singapore Programme of Research Investigating New Approaches to Treatment of Tuberculosis (SPRINT-TB) and is also leading trials exploring pathogenesis and management of Klebsiella liver abscess.

Read Less

Martin
Dr. Martin Mengel, Spain
AMP(Agence de Médecine Préventive)

Read More


Dr. Martin Mengel is the leader of the enteric diseases program and primary investigator of the VacciChol project on cholera vaccine use in endemic settings. Prior to this he served as director of the African Cholera Surveillance Network, “Africhol” (www.africhol.org). Africhol collected data on cholera disease burden in 11 sub-Saharan countries to determine the most appropriate interventions for cholera prevention and control, including vaccination and improvements in access to drinking water and sanitation. Dr Mengel chairs the working group for cholera surveillance and epidemiology at the World Health Organization.
Prior to joining AMP’s Africhol team in 2011, Dr Mengel completed the European Program for Intervention Epidemiology Training with the European Centre for Disease Prevention and Control and the National Center for Epidemiology, Madrid, Spain. He has worked on various public health projects worldwide including trans-national outbreak investigations, surveillance (H1N1, HIV-AIDS, food-borne disease), epidemic intelligence, and academic teaching. Before that, he worked as a pediatrician at the University Children’s Clinic of Cologne, Germany and as a study physician in clinical pharmacology. He has co-authored over 20 peer-reviewed publications on cholera and public-health with a focus on Africa.
Dr. Mengel holds an MSc in tropical diseases from the University of Valencia, Spain, an MD from the University of Bonn, Germany, a MSE in field epidemiology from the National School of Health in Madrid, Spain and is a visiting professor at the University of Maastricht and the Ecole des hautes études en santé publique , Rennes, France.

Read Less

Ralph
Dr. Ralph Ternier
PIH

Read More


Dr. Ternier is a long time PIH physician working in Global Health. Based in Haiti he currently runs the community activities in both central Haiti Artibonite region. As his team diagnosed the first cholera cases in October 2010, he’s been involved since in the fight for the eradication of the disease in the country. In 2012, with his colleagues he helped piloting the first ever cholera vaccination in one of the most affected areas in the country.

The success of such initiative allowed the government to conduct many other campaigns.
Dr Ternier is constantly assisting in many aspects of the cholera management the Ministry of Health of Haiti to operationalize the cholera elimination plan elaborated by the two nations of the Hispaniola Island.

Read Less


Dr. Dominique Legros, France
WHO

Read More


Dr Dominique Legros is a Medical Doctor who also studied public health, tropical medicine, epidemiology and emergency medicine in France, Belgium and the USA.

He began his career in international health in Bamako, Mali in 1990. Over the last 25 years, he occupied several technical and managerial positions in WHO, Epicentre, Médecins sans Frontières, Médecins du Monde and the French aid agency. His areas of expertise include the epidemiology of infectious diseases in developing countries, surveillance, nutrition, vaccinology, operational research, and the management of outbreaks and of complex emergencies. Dr Legros has worked in Europe, South America, Asia and Africa. He is now in charge of the cholera program, based in WHO headquarters in Geneva, Switzerland.

Read Less

Namseon
Dr. Namseon Beck, Korea
International Vaccine Institute

Read More


Namseon Beck, M.D. is an expert on clinical medicine in pediatrics & gastroenterology, global health and humanitarian response including communicable disease outbreak response and vaccine delivery. He was appointed as a Program Director, Delivery with the IVI in January 2017.

His professional experience covers Asia, Middle East, and Africa. Dr. Beck has been involved in Clinical Care, Humanitarian Response & Mitigation, and Monitoring & Evaluation with operational research at a medical school in Korea, a research institute, and humanitarian organizations. Before joining IVI, he has been working as senior health & nutrition Advisor for international humanitarian NGOs including Medair, Medical Teams International and Save the Children based in Switzerland and US. He also intermittently provided consultation to national MOHs, WHO and World Bank for outbreaks responses including yellow fever and Ebola in DRC and Liberia respectively.

Dr. Beck earned his state doctorate of medicine at the Seoul National University, the board certification in both pediatrics and gastroenterology & nutrition from Seoul National University Hospital, and a diploma of public health from London School of Hygiene and Tropical Medicine.

Read Less

Lois
Lois Privor-Dumm, USA
International Vaccine Access Center (USA), Johns Hopkins University

Read More


Ms. Lois Privor-Dumm is a Managing Director and the Policy, Advocacy & Communications Team Lead at IVAC, Johns Hopkins Bloomberg School of Public Health. She works with governments, civil society and the international health community to help advocate for and accelerate equitable and sustainable vaccine programs in low and middle-income countries.

Read Less

Saidatul
Saidatul Norbaya Buang, Malaysia
Ministry of Health

Read More


Dr Saidatul Norbaya Buang is a Public Health Physician currently attached with the Family Health Development Division, Ministry of Health Malaysia. She has 20 years experience in programme planning and implementation in adolescent health, school health and Thalassemia prevention programme in primary care. Dr Saidatul pioneered the implementation of HPV immunisation programme for school children in Malaysia since 2010. Among her other major involvements include networking with Ministry of Education in the area of policy for the expansion of school based health services such as support for Ministry of Education Literacy Programme through development of guidelines in assessment and diagnosis of school children with learning disabilities and the recent Thalassemia screening programme.

Read Less


Frédéric Debellut, Switzerland
PATH

Read More


Frédéric Debellut is a Health Economist working for the Center for Vaccine Innovation and Access at PATH. He provides technical support to countries in carrying out a range of economic evaluations including costing analysis of new vaccine introductions and cost effectiveness analysis. His work also involves forecasting demand for different vaccines.

Frédéric Debellut is an health economist with 10 years international experience in managing health related projects both at global and country levels with a specific focus on immunization. His current work involves providing direct Technical Assistance to Expanded Program on Immunization (EPI) teams in Gavi eligible and non Gavi countries undertaking health economic evaluations linked to new vaccine introductions. He is also responsible for regularly updating and sharing results of various demand forecast models. In previous years, Frédéric was the Project Manager for the Vaccine Implementation Technical Assistance Consortium (VITAC), a Gavi funded effort aiming at strengthening new vaccine introductions in Low and Middle Income Countries. He also collaborated with WHO in coordinating the development and roll out of their Immunization repository, an integrated data management system that allows Gavi partners to manage, access, and share critical immunization information. Prior to joining PATH, Frédéric was Project Operations Manager at Agence de Médecine Préventive, where he managed several multi-country projects, with a special emphasis on Health Economics, Medical Anthropology, Influenza and Respiratory Viruses-related projects. His country experiences include several years with different nonprofit organizations in the Democratic Republic of the Congo, Haiti, Myanmar and Thailand. Frédéric holds a Master’s degree in Health Economics with a focus on Low and Middle Income Countries and a Bachelor’s degree in Economic Science and Business Management.

Read Less

October
October M. Sessions
Duke-NUS Medical School, Singapore

Read More


October is an Assistant Professor at the Duke-NUS Medical School in Singapore. He has a particular interest in the mechanisms that define the pathogenic potential of flaviviruses. His laboratory frequently utilizes high-throughput sequencing and more traditional molecular genetics and microbiological techniques to elucidate these mechanisms in the human and mosquito hosts. In collaboration with clinical partners both local and international, he is applying these tools to study the emergence of novel pathogens as well as known pathogens with novel clinical manifestations/associations.

Read Less

Pornthep
Pornthep Chanthavanich

Read More


Pornthep Chanthavanich is an Associate Professor at the Department of Tropical Pediatrics, Faculty of Tropical Medicine, Mahidol University. He graduated in medicine from Siriraj Medical School, Mahidol University. He holds postgraduate qualifications in DTM&H (Bangkok), MSc.MCH (London), DTCH (Liverpool), Dip. Thai Board of Pediatrics Infectious Diseases, Dip. Thai Board of Preventive Medicine (Travel Medicine). He was previously Head of the Department of Tropical Pediatrics, Deputy Director of Hospital for Tropical Diseases (Bangkok), and Deputy Dean of Faculty of Tropical Medicine, Mahidol University. He is now the President of Thai Society of Travel Medicine, President of Asia Pacific Travel Health Society, Secretary General of Asian Society for Pediatric Infectious Diseases, Treasurer of International Society of Tropical Pediatrics. His research interests have been in travel medicine, vaccines, tropical medicine, and infectious diseases.

Read Less


© ASVAC 2017 | All Rights Reserved | Sitemap

Organized by:



Managed by:



c/o Kenes Asia (Thailand) Co., Ltd.
PICO Building, 10 Soi Lasalle 56, Sukhumwit
Bangna, Bangkok 10260
Thailand
Tel: +662 7487881
Fax: +662 7487880
Email: asvac2017@kenes.com